Health officials prepare for West Nile virus

InnovationRx delivers healthcare news every week. To receive it in your inbox, Subscribe here.

Health officials across the U.S. are warning of a return of seasonal flu. West Nile viruswhich Deadly Disease It’s a disease with no cure or vaccine. Warning was issued earlier this year. Changing climatic conditions Environments across the country are becoming more hospitable to disease-carrying mosquitoes.

According to the CDC: 1,000 and 10,000 people About 1,000 people become infected each year in the U.S. About 80% of those infected don’t develop symptoms, but the 20% who do tend to experience severe symptoms. West Nile fever Symptoms include fever, headache, pain, nausea, rash and vomiting. Malaise Symptoms caused by the infection can last from several weeks to several months and, in a small number of cases, can affect the central nervous system, increasing the risk of death.

there is no vaccine A West Nile virus epidemic is expected in the near future. Various medications There have been tests done to date to treat this disease, but none have shown any real effectiveness. This means that the best way to avoid the disease at this time is to: Mosquito bites.

You can find out more about this disease here.

Billionaire Groupon founder Eric Lefkofsky’s health tech company goes public for the fourth time

Five years ago, Chicago-based billionaire serial entrepreneur Eric Lefkofsky told Forbes he wanted Tempus AI, a health analytics and precision medicine company, to be his “legacy project.” The company is now his most valuable asset and his fourth company to go public.

Lefkofsky founded Tempus in 2015 after his wife was diagnosed with breast cancer and he was “disturbed by how little data had permeated her care.” Tempus started as an oncology-focused company, sequencing tumor samples from cancer patients and analyzing them with machine learning-trained models to determine more accurate diagnoses and personalized treatments, and has gradually expanded into other disease areas, including neuropsychiatry, radiology and cardiology.

The company, which began trading on the Nasdaq on Friday, now has 2,300 employees and its customers include more than 2,000 healthcare providers that send patient samples for testing, as well as 19 of the world’s 20 largest pharmaceutical companies, which license Tempus’ vast amounts of data for drug discovery.

Please see here for the detail.

Pipeline and Deal Updates

vaccine: The FDA has approved Merck’s Capvaxive vaccine, which is used to protect against bacteria that cause pneumonia, bacteremia and meningitis.

Company formation: Marea Therapeutics, a biotechnology company developing drugs to treat cardiometabolic diseases, today announced it has raised a total of $190 million in combined A and B funding.

AI Drug Discovery: Enveda Biosciences, which uses a machine learning platform to identify promising drug candidates in nature, announced it has closed a $55 million funding round.

leukemia: Takeda announced that it has entered into an option agreement with Ascentage Pharma for an exclusive license to olverenmatinib, a drug candidate for the treatment of chronic myeloid leukemia and other blood cancers. Ascentage will receive an upfront payment of $100 million, plus other payments and royalties if Takeda exercises the option.

MIT spinout The Engine Ventures raises $398 million in new fund to tackle technology’s toughest problems

Enjin Ventures has raised its third fund, closing on a total of $398 million, nearly double the size of its second fund. The MIT spinout venture firm invests in many advanced technology areas, including human health. For example, one of its portfolio companies, Vaxess, is working on developing a patch to deliver vaccines and biologics in a way that reduces the need for cold chains and syringes. This could make these treatments more accessible to parts of the world that lack large medical infrastructure.

Please see here for the detail.

More Healthcare News

of Two executives arrested The announcement by telemedicine pharmaceutical company Done could have the unintended consequence of worsening a nearly two-year-old ADHD medication shortage, disrupting treatment for more than 50,000 patients across the country.

The Department of Defense is secretly Anti-vaccination movement A shocking investigation published by Reuters on Friday morning revealed that the attack targeted China’s vaccination efforts in the Philippines at the peak of the COVID-19 pandemic.

Abortion pills Mifepristone The Supreme Court on Thursday ruled unanimously in favor of the government in a case seeking further restrictions on medication abortions, meaning government approval will not be overturned.

Amazon Pharmacy Rx PassThe service, which offers “unlimited access to 60 eligible prescription drugs with fast, free delivery for just $5 per month,” is now available to Prime members with Medicare coverage.

Some states are expanding Scope of work for pharmacists This is to allow doctors, who are facing shortages of family doctors and other medical professionals, to prescribe the medicines.

Forbes Overall

The robotaxi business is Elon Musk’s dream, but it’s already a reality for Waymo

Is your money really safe in an “FDIC insured” fintech account?

Honor My Father: A Drug Smuggler’s Son’s Story

What else am I reading?

I’m a hypochondriac. How should the health care system deal with people like me? (Statistics)

When therapists lose their licenses, some turn to the unregulated life coaching industry (ProPublica)

Ascension Catholic Hospital Outsources Staffing to Private Equity-Owned Partner (Religion News)